Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides
- PMID: 20150726
- DOI: 10.1159/000283561
Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides
Abstract
Background: Patients with highly increased plasma triglyceride levels are at risk of developing serious complications such as pancreatitis, coronary heart disease and stroke. Therefore it is important to rapidly decrease plasma triglyceride levels. A sufficient control of triglyceride levels with drugs like fibrates, statins or nicotinic acid can usually only be attained after a couple of weeks. Plasma exchange appears to be a fast but expensive method to reduce triglyceride levels. In this study we describe the use of a new omega-3 fatty acid and medium-chain triglyceride-rich formula diet as a therapeutic concept to reduce plasma triglyceride levels fast and effectively.
Methods: Thirty-two patients with severe hypertriglyceridemia were treated with the especially composed formula diet for a period of 7 days.
Results: Within this period of time, plasma triglycerides decreased from 1,601 (402-4,555) to 554 (142-2,382) mg/dl (p < 0.05). Total cholesterol levels were reduced from 417 (211-841) to 287 (165-457) mg/dl (p < 0.001). Fasting glucose and uric acid levels also slightly decreased (-8%; -12%). The formula diet as a 1-week treatment was well tolerated and accepted by the patients.
Conclusion: This diet was successfully used as an acute treatment in severe hypertriglyceridemia and showed effectiveness in rapidly and safely lowering plasma triglyceride levels.
(c) 2010 S. Karger AG, Basel.
Similar articles
-
Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.Clin Infect Dis. 2005 Nov 15;41(10):1498-504. doi: 10.1086/497273. Epub 2005 Oct 11. Clin Infect Dis. 2005. PMID: 16231263 Clinical Trial.
-
Successful long-term treatment of severe hypertriglyceridemia by feedback control with lipid self-monitoring.Ann Nutr Metab. 2008;52(3):215-20. doi: 10.1159/000138126. Epub 2008 Jun 11. Ann Nutr Metab. 2008. PMID: 18544976
-
The effect of lean fish consumption on triglyceride levels.Phys Sportsmed. 2009 Apr;37(1):37-43. doi: 10.3810/psm.2009.04.1681. Phys Sportsmed. 2009. PMID: 20048486 Clinical Trial.
-
Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.Pharmacotherapy. 2007 May;27(5):715-28. doi: 10.1592/phco.27.5.715. Pharmacotherapy. 2007. PMID: 17461707 Review.
-
Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.Atherosclerosis. 2015 Oct;242(2):647-56. doi: 10.1016/j.atherosclerosis.2015.06.012. Epub 2015 Jun 11. Atherosclerosis. 2015. PMID: 26296750 Review.
Cited by
-
Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.Vasc Health Risk Manag. 2012;8:187-95. doi: 10.2147/VHRM.S28739. Epub 2012 Mar 20. Vasc Health Risk Manag. 2012. PMID: 22536073 Free PMC article. Clinical Trial.
-
β-hydroxybutyrate and ischemic stroke: roles and mechanisms.Mol Brain. 2024 Jul 29;17(1):48. doi: 10.1186/s13041-024-01119-0. Mol Brain. 2024. PMID: 39075604 Free PMC article. Review.
-
Hypertriglyceridemia may contribute to stroke and pancreatitis: A case report and review of the literature.Front Endocrinol (Lausanne). 2022 Dec 1;13:960343. doi: 10.3389/fendo.2022.960343. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531479 Free PMC article. Review.
-
Management of Hypertriglyceridemia Induced Acute Pancreatitis.Biomed Res Int. 2018 Jul 26;2018:4721357. doi: 10.1155/2018/4721357. eCollection 2018. Biomed Res Int. 2018. PMID: 30148167 Free PMC article. Review.
-
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.Metabolites. 2023 Apr 30;13(5):621. doi: 10.3390/metabo13050621. Metabolites. 2023. PMID: 37233662 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical